Your browser doesn't support javascript.
loading
Modeling of bioprocess pre-stages for optimization of perfusion profiles and increased process understanding.
Pogodaev, Aleksandr; Hernández Rodríguez, Tanja; Li, Mengyao; García Münzer, David Gerardo.
Afiliação
  • Pogodaev A; Novartis Technical Research & Development, Basel, Switzerland.
  • Hernández Rodríguez T; Novartis Technical Research & Development, Holzkirchen, Germany.
  • Li M; Novartis Technical Research & Development, Basel, Switzerland.
  • García Münzer DG; Novartis Technical Research & Development, Basel, Switzerland.
Biotechnol Bioeng ; 121(1): 228-237, 2024 01.
Article em En | MEDLINE | ID: mdl-37902718
ABSTRACT
Improving bioprocess efficiency is important to reduce the current costs of biologics on the market, bring them faster to the market, and to improve the environmental footprint. The process intensification efforts were historically focused on the main stage, while intensification of pre-stages has started to gain attention only in the past decade. Performing bioprocess pre-stages in the perfusion mode is one of the most efficient options to achieve higher viable cell densities over traditional batch methods. While the perfusion-mode operation allows to reach higher viable cell densities, it also consumes large amount of medium, making it cost-intensive. The change of perfusion rate during a process (perfusion profile) determines how much medium is consumed, thereby running a process in optimal conditions is key to reduce medium consumption. However, the selection of the perfusion profile is often made empirically, without full understanding of bioprocess dynamics. This fact is hindering potential process improvements and means for cost reduction. In this study, we propose a process modeling approach to identify the optimal perfusion profile during bioprocess pre-stages. The developed process model was used internally during process development. We could reduce perfused medium volume by 25%-45% (project-dependent), while keeping the difference in the final cell within 5%-10% compared to the original settings. Additionally, the model helps to reduce the experimental workload by 30%-70% and to predict an optimal perfusion profile when process conditions need to be changed (e.g., higher seeding density, change of operating mode from batch to perfusion, etc.). This study demonstrates the potential of process modeling as a powerful tool for optimizing bioprocess pre-stages and thereby guiding process development, improving overall bioprocess efficiency, and reducing operational costs, while strongly reducing the need for wet-lab experiments.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reatores Biológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reatores Biológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article